APA

Giuliani S., Leonardi E., Aldovini D., Bernardi D., Pellegrini M., Soli F., Ferro A., Dalla Palma P., Decarli N. & Barbareschi M. (20120917). Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy. : Pathologica.

Chicago

Giuliani S, Leonardi E, Aldovini D, Bernardi D, Pellegrini M, Soli F, Ferro A, Dalla Palma P, Decarli N and Barbareschi M. 20120917. Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy. : Pathologica.

Harvard

Giuliani S., Leonardi E., Aldovini D., Bernardi D., Pellegrini M., Soli F., Ferro A., Dalla Palma P., Decarli N. and Barbareschi M. (20120917). Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy. : Pathologica.

MLA

Giuliani S, Leonardi E, Aldovini D, Bernardi D, Pellegrini M, Soli F, Ferro A, Dalla Palma P, Decarli N and Barbareschi M. Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy. : Pathologica. 20120917.